Transforming medicine through precision epigenomic control, Mahesh Karande, Pres. & CEO, Omega Tx
Synopsis: Mahesh Karande is the President and CEO of Omega Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines for...
13 Syys 202329min
Catalyzing the next generation of mRNA medicines, Joseph Payne, Founder, Pres. & CEO, Arcturus Tx
Synopsis: Joseph Payne is the Founder, President and CEO of Arcturus Therapeutics, a global late-stage clinical messenger RNA medicines and vaccines company focused on the discovery, development and ...
6 Syys 202329min
Advancing muscle biology, Robert Blum, Pres. & CEO, & Fady Malik, EVP, Research & Dev., Cytokinetics
Synopsis: Robert Blum and Fady Malik are the President & CEO and EVP, Research and Development, respectively, of Cytokinetics, a late-stage biopharmaceutical company committed to developing potenti...
30 Elo 202329min
Transforming the treatment of neuromuscular diseases, James McArthur, CEO, PepGen
Synopsis: James McArthur is the CEO of PepGen, a biotech company creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious ge...
23 Elo 202328min
Conquering new frontiers in cell therapy, Paul Lammers, CEO, Triumvira Immunologics
Synopsis: Paul Lammers, M.D., is the CEO of Triumvira Immunologics, a clinical-stage immuno-oncology company developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the...
16 Elo 202333min
Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma
Synopsis: Andrew Scharenberg is the Co-founder and CEO of Umoja Biopharma, a company pioneering the future of immunotherapy by reprogramming T cells in vivo. Umoja’s groundbreaking integrated platfor...
9 Elo 202332min
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx
Synopsis: Theresa Heah, M.D., is the CEO of Intergalactic Therapeutics. Intergalactic is overcoming the limitations of viral-based gene therapy and developing a best-in-class non-viral alternative. I...
2 Elo 202319min
Transforming diseased cells into coordinators of cure, Volker Herrmann, President & CEO, Sonata Tx
Synopsis: Volker Herrmann is the President and CEO of Sonata Therapeutics, a Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance...
26 Heinä 202334min
